We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Seville, Spain

ICHNO 2026

Session

Friday
March 20
10:30 - 11:30
New insights on side effects and quality of life
Shao Hui Huang, Canada;
William Lydiatt, USA
Proffered Papers
10:30 - 11:30
REALKEY study: patient-reported outcomes in recurrent/metastatic head and neck cancer treated with first-line immunotherapy +/- chemotherapy
Marc Oliva Bernal, Spain
-246
10:30 - 11:30
Real-world outcomes of immunotherapy ± chemotherapy in older patients with head and neck cancer. A sub-analysis of the REALKEY Study
Matteo Carpani, Italy
-416
10:30 - 11:30
Secondary endpoint analysis of the BD4QoL randomized trial (NCT05315570): domain-specific quality of life changes in head and neck cancer survivors
Stefano Cavalieri, Italy
-367
10:30 - 11:30
Neurocognitive Outcomes Following Photon and Proton Radiotherapy in Oropharyngeal Cancer
Zsuzsanna Iyizoba-Ebozue, United Kingdom
-211
10:30 - 11:30
Associations between patient-reported neurocognition, mood, and fatigue and radiation dose in head and neck cancer survivors
Zsuzsanna Iyizoba-Ebozue, United Kingdom
-116
10:30 - 11:30
Acute Ototoxicity During Cisplatin Concurrent Chemoradiation (CCRT) in Oropharyngeal Carcinoma (OPSCC): Clinical Impact and Risk Factors
Haydee Williams Sanchez, Mexico
-509
10:30 - 11:30
Deep learning multi-toxicity prediction model in head and neck cancer radiotherapy patients
Lisanne van Dijk, The Netherlands
-256